
Summary
Invetx is a biotechnology company, a division of Dechra Pharmaceuticals, focused on developing novel, protein-based therapeutics for dogs and cats, aiming to transform veterinary care for chronic conditions like pain, allergy, and cancer.
Deals Overview
Senior Management
Juergen Horn
CEO
Jeff Troderman
CFO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite